We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 622% below its sector, cheaper than its peers on earnings.
Anterogen.Co.,Ltd., a South Korean bio-venture founded in 2000 and headquartered in Seoul, specializes in the global research, development, and commercialization of therapeutic products utilizing adipose-derived stem cells. Their pharmaceutical offerings include Cupistem injection, an adipose stem cell product for treating Crohn's fistula; Queencell, a stromal vascular fraction aimed at regenerating subcutaneous adipose tissue; and Remodulin injection, which addresses pulmonary arterial hypertension. The company also produces a line of cosmetics, featuring SCM2 and SCM2-Black for hair care, and Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione for skin care, along with providing human stem cell conditioned media as a cosmetic raw material. Furthermore, Anterogen offers services such as cell banking and various analytical services, including sample analysis for clinical studies and biopharmaceutical testing for identification, purity, potency, and adventitious viruses.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 065660.KQ and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
